Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: Clinical and prognostic significance
Authors:
- Lidia RossiLRLidia Rossi
- Gianni SarassoGSGianni Sarasso
- Maria Domenica PrandoMPMaria Domenica Prando
- Angelo Sante BongoABAngelo Sante Bongo
- Pierfranco DellavesaPDPierfranco Dellavesa
- Paolo RossiPRPaolo Rossi
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Frequency and importance of silent myocardial ischemia identified with ambulatory electrocardiographic monitoring in the early in-hospital period after acute myocardial infarctionThe American Journal of Cardiology, 1990
- “Silent ischemia”: What is it?JACC, 1989
- High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: Correlation with exercise testing and coronary angiographyJACC, 1989
- Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the coronary artery surgery study (CASS) registryThe American Journal of Cardiology, 1988
- Prognostic significance of ischemic episodes in patients with previous myocardial infarctionThe American Journal of Cardiology, 1988
- Silent ischemia predicts infarction and death during 2 year follow-up of unstable anginaJACC, 1987
- Prognostic significance of silent myocardial ischemia in patients with unstable anginaJACC, 1987
- Significance of silent myocardial ischemia during exercise testing in patients with coronary artery diseaseThe American Journal of Cardiology, 1987
- Role of dipyridamole-echocardiography test in electrocardiographically silent effort myocardial ischemiaThe American Journal of Cardiology, 1986
- Prognosis and treatment of asymptomatic coronary artery diseaseJACC, 1983